FDA Rejects New Insomnia Drug Suvorexant, Seeks Lower Dose
Merck said it received a complete response letter from the U.S. Food and Drug Administration saying that the agency could
fda rejects new insomnia drug suvorexant seek lower dose merck say receive complete response letter  USA  food drug administration say agency